Literature DB >> 11248758

Polymorphism insertion/deletion of the ACE gene and ambulatory blood pressure circadian variability in essential hypertension.

R Julve1, F J Chaves, E Rovira, J M Pascual, A Miralles, M E Armengod, J Redon.   

Abstract

OBJECTIVE: The objective of the present study was to analyze the influence of the insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme on ambulatory blood pressure values and circadian variability in untreated patients with hypertension.
MATERIAL AND METHODS: Ninety-nine essential hypertensive patients, less than 50 years old (mean age 39.5+/-7.0 years), previously untreated with antihypertensive drugs were included. Twenty-four hour ambulatory blood pressure monitoring (ABPM) was performed with a Spacelabs (90202 and 90207) monitor, during a regular working day in unrestricted ambulatory conditions. The I/D polymorphism of the ACE was determined by PCR.
RESULTS: The distributions of genotypes were in Hardy-Weinberg equilibrium: I=17 (17%), ID=41 (41.5%), DD=41 (41.5%). No significant differences were present among the groups in terms of age, sex, and biochemical and lipid profiles. The average of 24-h ambulatory blood pressure was slightly higher in patients with the DD genotype as compared with patients with the II and ID genotypes. This was the result of higher nighttime blood pressure values, because no differences in blood pressure were observed during daytime. The systolic blood pressure (SBP) day:night ratio, as an estimate of circadian variability, was significantly lower in subjects homozygous for the D allele than it was in patients carrying the I allele (1.13+/-0.09 vs. 1.17+/-0.08, P=0.014). The subjects in the lowest tertile of the SBP day:night ratio, exhibited a higher frequency of the D allele when compared with those in the middle tertile (0.74 vs. 0.59, P<0.05) or with those in the highest tertile (0.74 vs. 0.54, P<0.01). By using two-way ANOVA with repeated measures, significant differences in SBP variation over time were observed when comparing homozygous for the D allele with subjects carrying the I allele (F=2.11, P=0.002).
CONCLUSIONS: Among the genotypes of the I/D polymorphism, subjects carrying DD genotype showed a blunted decline of the physiological nocturnal fall of blood pressure that was significant for SBP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11248758     DOI: 10.1097/00126097-200102000-00005

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  6 in total

Review 1.  Assessment and management of blood-pressure variability.

Authors:  Gianfranco Parati; Juan E Ochoa; Carolina Lombardi; Grzegorz Bilo
Journal:  Nat Rev Cardiol       Date:  2013-02-12       Impact factor: 32.419

2.  Effects of age, genes, and pulse pressure on executive functions in healthy adults.

Authors:  Naftali Raz; Cheryl L Dahle; Karen M Rodrigue; Kristen M Kennedy; Susan Land
Journal:  Neurobiol Aging       Date:  2009-06-25       Impact factor: 4.673

Review 3.  ACE2 and COVID-19: using antihypertensive medications and pharmacogenetic considerations.

Authors:  Eric M Snyder; Bruce D Johnson
Journal:  Pharmacogenomics       Date:  2020-06-05       Impact factor: 2.533

4.  Hypertension and Cerebral Microangiopathy (Cerebral Small Vessel Disease): Genetic and Epigenetic Aspects of Their Relationship.

Authors:  L A Dobrynina; M R Zabitova; L A Kalashnikova; E V Gnedovskaya; M A Piradov
Journal:  Acta Naturae       Date:  2018 Apr-Jun       Impact factor: 1.845

5.  The Effect of Genetically Guided Mathematical Prediction and the Blood Pressure Response to Pharmacotherapy in Hypertension Patients.

Authors:  Eli F Kelley; Thomas P Olson; Timothy B Curry; Ryan Sprissler; Eric M Snyder
Journal:  Clin Med Insights Cardiol       Date:  2019-05-03

6.  Angiotensin-converting enzyme insertion/deletion polymorphism, 24-h blood pressure profile and left ventricular hypertrophy in hypertensive individuals: a cross-sectional study.

Authors:  Luciana Neves Cosenso-Martin; Renan Oliveira Vaz-de-Melo; Luana Rocco Pereira; Cláudia Bernardi Cesarino; Juan Carlos Yugar-Toledo; José Paulo Cipullo; Marcela Augusta de Souza Pinhel; Dorotéia Rossi Silva Souza; José Fernando Vilela-Martin
Journal:  Eur J Med Res       Date:  2015-09-04       Impact factor: 2.175

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.